Clinical reference Biomarker Directory
Back to directory

C3

Established

C3 is the central complement protein whose deficiency causes severe recurrent bacterial infections.

Also known as Complement component 3
In plain language

C3 is the central hub of the complement immune defense system. Without it, the body struggles badly to fight off certain bacteria, since C3 is needed to mark germs for destruction no matter which defense pathway starts the process.

Biomarker & context

C3 is the central protein of the entire complement system, activated by all three complement pathways (classical, alternative, lectin) and generating C3b, the system's key opsonin that tags pathogens for immune destruction.

What it indicates

C3 deficiency causes severe, recurrent infections with encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae) due to impaired opsonization, distinct from the autoimmune pattern seen with earlier classical-pathway component deficiencies.

Diagnosis & clinical testing

Screened via both CH50 (classical pathway) and AH50 (alternative pathway) — both are abnormal in C3 deficiency since C3 is shared by all pathways, distinguishing it from isolated early classical-pathway defects.

Guiding treatment

Because C3-deficient patients face severe, life-threatening infection risk, management prioritizes vaccination, prophylactic antibiotics, and aggressive treatment of any infection; poor prognosis without prophylaxis is well documented.

Clinical significance

Central convergence point of all complement pathways; deficiency carries the highest infection-related mortality risk among complement defects.

References
  1. ScienceDirect Topics. Complement Deficiency — an overview.
  2. PMC. (2024). Complements and Their Role in Systemic Disorders.